Reference health

Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma

https://doi.org/10.3390/cancers11101502
CiteStamped reference-health badge
40/40 checkable references clean · checked 2026-07-24

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 40 checked references that resolve
resolves10.1016/j.jtho.2018.02.021
Progress in the Management of Malignant Pleural Mesothelioma in 2017
resolves10.12688/f1000research.15796.1
Multimodality treatment of malignant pleural mesothelioma
resolves10.1183/16000617.0063-2016
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
resolves10.1038/bjc.2013.731
An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma
resolves10.1200/JCO.2003.11.136
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
resolves10.1038/ng.3520
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
resolves10.1158/2159-8290.CD-18-0804
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
resolves10.1158/0008-5472.CAN-14-1008
Whole-Exome Sequencing Reveals Frequent Genetic Alterations in <i>BAP1</i> , <i>NF2</i> , <i>CDKN2A</i> , and <i>CUL1</i> in Malignant Pleural Mesothelioma
resolves10.1038/ng.855
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
resolves10.1016/j.lungcan.2018.11.034
Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018)
resolves10.1016/j.trecan.2016.06.004
Adaptive Stress Responses During Tumor Metastasis and Dormancy
resolves10.1016/j.cell.2016.12.004
Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer
resolves10.3390/ijms160817193
Protein Folding and Mechanisms of Proteostasis
resolves10.15430/JCP.2014.19.2.75
Endoplasmic Reticulum Stress and Cancer
resolves10.1016/j.trecan.2016.03.007
Endoplasmic Reticulum Stress and the Hallmarks of Cancer
resolves10.1016/j.bbamcr.2013.06.028
ER stress-induced cell death mechanisms
resolves10.1016/j.bbamcr.2017.07.008
Regulated proteolysis as an element of ER stress and autophagy: Implications for intestinal inflammation
resolves10.1038/nrneurol.2017.99
ER stress and the unfolded protein response in neurodegeneration
resolves10.1155/2018/4946289
Targeting the Endoplasmic Reticulum Unfolded Protein Response to Counteract the Oxidative Stress‐Induced Endothelial Dysfunction
resolves10.1016/j.ejphar.2019.172553
Endoplasmic reticulum stress: A master regulator of metabolic syndrome
resolves10.4172/2157-2518.S6-002
Current Concepts in ER Stress-Induced Apoptosis
resolves10.1172/JCI26373
Endoplasmic reticulum stress: cell life and death decisions
resolves10.1038/s41416-018-0145-3
Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma
resolves10.4161/23723556.2014.975089
Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
resolves10.1016/j.ccell.2016.05.006
Gr(i)p the ER to Stress Out Melanoma
resolves10.1016/j.ccell.2016.04.013
Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance
resolves10.1016/j.mce.2018.02.010
The GRP78/BiP inhibitor HA15 synergizes with mitotane action against adrenocortical carcinoma cells through convergent activation of ER stress pathways
resolves10.1016/S0002-9440(10)62492-3
Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling
resolves10.1093/annonc/mdu127
Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications
resolves10.1038/s41589-019-0326-2
Pharmacological targeting of the unfolded protein response for disease intervention
resolves10.1073/pnas.1516362112
Type I interferons mediate pancreatic toxicities of PERK inhibition
resolves10.1152/ajpcell.00258.2014
Cellular Mechanisms of Endoplasmic Reticulum Stress Signaling in Health and Disease. 1. An overview
resolves10.1016/j.cell.2015.05.025
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
resolves10.1172/JCI74056
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis
resolves10.1016/j.immuni.2014.08.015
The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors
resolves10.1038/35014014
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response
resolves10.1111/j.1349-7006.2006.00184.x
Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients
resolves10.1186/s13287-016-0282-7
Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines
resolves10.1038/cddis.2015.195
Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer
resolves10.1038/s41388-018-0479-6
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer
The 4 references without a DOI — listed, not checked
no DOI — not checkedTravis, W.D., Brambilla, E., Burke, A.P., Marx, A., and Nicholson, A.G. (2015). WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart, International Agency for Research on Cancer. [4th ed.].
no DOI — not checkedAdvances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma
no DOI — not checkedThe unfolded protein response as a target for cancer therapy
no DOI — not checkedSuppression of OCT4B enhances sensitivity of lung adenocarcinoma A549 cells to cisplatin via increased apoptosis
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-24 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.3390/cancers11101502"><img src="https://citestamp.com/citestamped/10.3390/cancers11101502/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.3390/cancers11101502/badge.svg)](https://citestamp.com/citestamped/10.3390/cancers11101502)